— Multiple near-term anticipated product launches and development of innovative immuno-oncology pipeline position Coherus for long-term growth –
— Introducing 2026 revenue target of $1.2 billion in annual net sales from Coherus' diversified product portfolio –
Read more at globenewswire.com